(Q43178455)

15 November 2017

The efficacy of ibrutinib in the treatment of Richter syndrome (English)

1 reference

15 November 2017

1 reference

2

Tait D Shanafelt

1 reference

15 November 2017

3

Timothy G Call

1 reference

15 November 2017

11

Susan L Slager

1 reference

15 November 2017

10

Susan M Schwager

1 reference

15 November 2017

12

Neil E Kay

1 reference

15 November 2017

8

Deborah Bowen

1 reference

15 November 2017

Mazie Tsang

1

1 reference

15 November 2017

Wei Ding

4

1 reference

15 November 2017

Asher Chanan-Khan

5

1 reference

15 November 2017

Jose F Leis

6

1 reference

15 November 2017

Grzegorz S Nowakowski

7

1 reference

15 November 2017

Michael Conte

9

1 reference

15 November 2017

Curtis A Hanson

13

1 reference

15 November 2017

Sameer A Parikh

14

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 March 2015

1 reference

15 November 2017

1 reference

15 November 2017

125

1 reference

15 November 2017

10

1 reference

15 November 2017

1676-1678

1 reference

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

How we treat Richter syndrome

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma wor

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

Revised response criteria for malignant lymphoma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4351511

10.1182/BLOOD-2014-12-610782

15 August 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

25745187

1 reference